Fosun Pharmaceutical launched Azf's fixed -film commercialization, emergency transfer to Henan, Hainan, Xinjiang and other places

Dahe.com Dahe.com (www.dahe.cn) -The only key news website in Henan Province, hosted by Henan Daily Newspaper Group, is the most authoritative Internet news media in Henan Province. Contact number: 4006371669

169 original content

the public

On August 11, the reporter from the Dahe Daily · Dahecai Cube learned from Fosun Pharmaceutical that Fosun Pharmaceutical Combined Real Biological Emergency Architecture Anti -New Crown Pneumonic Pneumonia Pharmaceutical Oral Drugs Azf will support many places across the country. Recently Hainan, Xinjiang and other places.

Azf's fixed film is my country's first approval to have completely independent intellectual property rights and global patent 1.1 category anti -new crown pneumonia small molecules oral drugs. According to the price of medical insurance networks in various places, Azf's fixed price is priced at 270 yuan per bottle, 35 tablets per bottle, and 1 mg per piece.

On July 20, 2021, the State Drug Administration had the conditions to approve the real biotechnology Azf fixed tablet and other reverse-transliterase inhibitors for the treatment of high-virus loads.

On July 25, 2022, the Emergency Conditions of the State Drug Administration approved the real creature Azf fixed tablet to increase the application of new coronary pneumonia treatment indications for the treatment of adult patients with COVID-19).

On August 9, the General Office of the National Health and Health Commission and the Office of the State Administration of Traditional Chinese Medicine issued a notice saying that Azf's fixed tablet was included in the "New Coronary Virus Pneumonia Diagnosis and treatment plan (ninth edition)". According to the "diagnosis and treatment plan", Azf's fixed tablet is used to treat adult patients with COVID-19). The amount of usage is swallowed by the entire space, 5mg each time, once a day, the course of treatment is not more than 14 days.

The reporter learned that on July 25, Fosun Pharmaceutical announced a strategic cooperation with Henan Real Biotechnology Co., Ltd., which will jointly develop and be exclusively commercialized by the holding subsidiary Fosun Pharmaceutical Industry Azfdin. Fosun Pharmaceutical will continue to pay close attention to the situation of this round of epidemic, and has made corresponding commercial deployments, and cooperates with partners to ensure the production and supply of drugs, and effectively meet the needs of the first -line prevention and control of the epidemic.

Source: Dahe Daily · Dahecai Cube copyright belongs to the original author if there is any infringement, please contact to delete

Responsible editor: Han Miaoyu review: Jiang Qiuxia

- END -